Results 121 to 130 of about 19,199 (220)

Comparative Safety Analysis of Targeted Synthetic and Biologic Disease‐Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis: A Nationwide Cohort Study in Japan

International Journal of Rheumatic Diseases, Volume 29, Issue 9, September 2026.
ABSTRACT Aim To compare risks of malignancy, opportunistic infections, and venous thromboembolism between the targeted synthetic disease‐modifying antirheumatic drugs (tsDMARDs) and biologic DMARDs (bDMARDs) at the 2nd and 3rd lines of therapy (LOT). Methods We conducted a cohort study using the National Database of Health Insurance Claims (2013–2021).
Shiori Nishimura, Toshitaka Hirano, Soko Setoguchi, Hiroki Matsui, Yoshinori Takeuchi, Yasushi Inoue, Yoshiya Tanaka, Kunihiro Yamaoka, Yoichi Ii, Shintaro Hiro, Masato Hoshi, Naonobu Sugiyama, Yutaka Matsuyama, Hiraku Kumamaru   +13 more
wiley   +1 more source

Disease activity category definitions for DAS28-CRP and MBDA.

, 2013
Disease activity category definitions for DAS28-CRP and MBDA.
Mary Turner (68044), Lyndal K. Hesterberg (400734), Guy Cavet (6287), Michael Centola (3348), Kathryn A. Swan (400729), Nicholas Knowlton (56215), Peter C. Taylor (400736), Jeffrey R. Curtis (400737), David Chernoff (400733), Chris Sutton (400730), Nancy A. Shadick (395872), Douglas J. Haney (400732), John P. Carulli (400735), Michael E. Weinblatt (395874), Dustin R. Smith (400731), Yijing Shen (400727), Saroja Ramanujan (400728)   +16 more
core   +1 more source

Timing of DAS28 in infliximab therapy: reply [PDF]

Rheumatology, 2005
P. Durez, F. Van den Bosch, L. Corluy, E. Veys, L. De Clerck, A. Peretz, M. Malaise, J.-P. Devogelaer, N. Vastesaeger, A. Geldhof, R. Westhovens   +10 more
openaire   +1 more source

PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study

Reumatismo
Purpose. To evaluate the data from the UPHOLD study on long-term achievement of treatment targets, sustained clinical response and safety of UPA over 2-years in patients with RA. Methods.
Società Italiana di Reumatologia
doaj   +1 more source

Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP

, 2016
Objectives: to investigate whether a difference exists between das28 from crP and das28 from esr in patients with rheumatoid arthritis (ra) and secondary sjögren's syndrome (sss).
PhD, MD Katarzyna Romanowska-Próchnicka, Piotr Wojdasiewicz, Szukiewicz, Małgorzata Mańczak, Katarzyna Romanowska-Próchnicka, Anna Felis-Giemza, Olesińska, Agnieszka Paradowska-Gorycka   +7 more
core  

Diagnostis Values Of Das28 And Das28-squeeze in Evaluating Rheumnatoid Arthirits Disease

In recent years, rheumatoid arthritis (RA) uses a "treat to target" treatment strategy. This strategy requires a valid and accurate tool for assessing disease activity. The most widely used tool is DAS28, which was developed from DAS whit the omission of
David Santosa
core  

Correlation Analysis of Coagulation and Platelet Parameters with Clinical Outcomes in Rheumatoid Arthritis Patients and the Interventional Effect of Jianpi Huashi Tongluo Formula - Xinfeng Capsule: A Post Hoc Analysis Based on an Randomized Controlled Trial

Drug Design, Development and Therapy
Fanfan Wang,1,2 Jian Liu,1,2 Yuan Wang,1,2 Yue Sun,2 Jianting Wen,1,2 Mingyu He1,2 1The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, 230031, People’s Republic of China; 2Department of Rheumatism Immunity, The First ...
Wang F, Liu J, Wang Y, Sun Y, Wen J, He M   +5 more
doaj  

Nonlinear association between platelet to albumin ratio and disease activity in patients with early rheumatoid arthritis

Scientific Reports
The relationship between the platelet to albumin ratio (PAR) and the disease activity of early rheumatoid arthritis (ERA) remains to be elucidated.
Lina Leng, Jingfang Shen, Lianju Li, Junfeng Li, Xiaoli Li, Dengxiang Liu   +5 more
doaj   +1 more source

DAS28 and RAPID3 comparison in rheumatoid arthritis patients

, 2013
Pamatojums. Reimatoīdais artrīts (RA) ir viena no visbiežāk sastopamajām autoimūnu slimību formām, kas ātri var sagraut cilvēka veselību. Novērtējot RA ietekmi uz cilvēku dzīves kvalitāti, šī slimība tiek uzskatīta kā viena no visvairāk dzīves kvalitāti ...
Vasiļjeva, Juna
core  

DAS28 un RAPID3 salīdzinājums reimatoīdā artrīta pacientiem

, 2015
Pamatojums. Reimatoīdais artrīts (RA) ir viena no visbiežāk sastopamajām autoimūnu slimību formām, kas ātri var sagraut cilvēka veselību. Novērtējot RA ietekmi uz cilvēku dzīves kvalitāti, šī slimība tiek uzskatīta kā viena no visvairāk dzīves kvalitāti graujošajām slimībām.
openaire   +1 more source